The escalation in opioid pain relief (OPR) medications, heroin and fentanyl, has led to an
increased use during pregnancy and a public health crisis. Methamphetamine use in …

The growing numbers of infants born to women with opioid use disorder (OUD) and
experiencing neonatal abstinence syndrome (NAS), and the increasing costs of their care, 1 …

The fetal movements during different gestational weeks are essential for normal
musculoskeletal development. The kinematic characteristics of fetuses with small differences …

Background and aims Intrauterine growth restriction (IUGR) can lead to significant
intellectual and behavioural problems in later life. IUGR represents a frequent feature of …

In 2002, another treatment option became available when the US Food and Drug
Administration (FDA) approved the use of buprenorphine as a treatment for opioid …

In this article, a broad overview of medication-assisted treatment (MAT) for opioid
dependence has been provided. Significant benefits of commonly used drugs …

Pregnancy presents a window of opportunity for effecting positive change in the lives of
women with opioid use disorder (OUD). Care should be empathetic and nonjudgmental with …

To assess potential risks related to the duration or total amount of fetal methadone exposure
during gestation, we compared babies of women who conceived and maintained on …

Illicit opioid use is a growing public health emergency and is associated with adverse
medical and social outcomes. Opioid use in the pregnant population is increasing globally …

BACKGROUND: Methadone therapy benefits heroin users in both the medical and
psychosocial dimensions. However, both heroin and methadone have cardiac toxicity. Only …